Showing results (361-370 of 367) with videos related to
Sort By:
Pageof 37
You have reached the last page of results.This site can display upto 367 results.
Arthritis and Rheumatism|August 4, 2011
Factors influencing the efficacy of two injections of a pandemic 2009 influenza A (H1N1) nonadjuvanted vaccine in systemic lupus erythematosusA Mathian, H Devilliers, A Krivine, et al.AIDS Research and Human Retroviruses|May 20, 1999
Safety and immunogenicity of a live recombinant canarypox virus expressing HIV type 1 gp120 MN MN tm/gag/protease LAI (ALVAC-HIV, vCP205) followed by a p24E-V3 MN synthetic peptide (CLTB-36) administered in healthy volunteers at low risk for HIV infection. AGIS Group and L'Agence Nationale de Recherches sur Le SidaD Salmon-Céron, J L Excler, L Finkielsztejn, et al.Ebiomedicine|December 24, 2017
What Is the most Important for Elite Control: Genetic Background of Patient, Genetic Background of Partner, both or neither? Description of Complete Natural History within a Couple of MSMM Bendenoun, A Samri, V Avettand-Fènoël, et al.Science (New York, N.Y.)|November 13, 1999
Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cellsZ Zhang, T Schuler, M Zupancic, et al.Proceedings of the National Academy of Sciences of the United States of America|April 12, 2000
Augmentation of immune responses to HIV-1 and simian immunodeficiency virus DNA vaccines by IL-2/Ig plasmid administration in rhesus monkeysD H Barouch, A Craiu, M J Kuroda, et al.The Journal of Infectious Diseases|January 13, 2012
Single-nucleotide polymorphism-defined class I and class III major histocompatibility complex genetic subregions contribute to natural long-term nonprogression in HIV infectionJ Guergnon, C Dalmasso, P Broet, et al.Science (New York, N.Y.)|October 20, 2000
Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccinationD H Barouch, S Santra, J E Schmitz, et al.Pageof 37